Business and Geographical Reporting Segments (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Business and Geographical Reporting Segments [Abstract] |
|
| Segment Reporting Information by Segment |
The following tables present results of operations from the Company’s business segments for the periods indicated below (in thousands, except gross profit %):
|
Year Ended December 31, 2025
|
|
Dermatology Recurring Procedures
|
|
|
Dermatology Procedures Equipment
|
|
|
Total
|
|
| |
|
|
|
|
|
|
|
|
|
|
Revenues, net
|
|
$
|
21,478 |
|
|
$
|
9,218 |
|
|
$
|
30,696 |
|
|
Cost of revenues
|
|
|
8,164 |
|
|
|
4,651 |
|
|
|
12,815 |
|
|
Gross profit
|
|
|
13,314 |
|
|
|
4,567 |
|
|
|
17,881 |
|
|
Gross profit %
|
|
|
62.0 |
%
|
|
|
49.5 |
%
|
|
|
58.3 |
%
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocated expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Engineering and product development
|
|
|
305 |
|
|
|
116 |
|
|
|
421 |
|
|
Selling and marketing
|
|
|
11,102 |
|
|
|
2,009 |
|
|
|
13,111 |
|
|
Unallocated expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
— |
|
|
|
— |
|
|
|
10,184 |
|
|
Settlement gains
|
|
|
— |
|
|
|
— |
|
|
|
(1,135 |
)
|
|
Total allocated and unallocated expenses
|
|
|
11,407 |
|
|
|
2,125 |
|
|
|
22,581 |
|
|
Income (loss) from operations
|
|
|
1,907 |
|
|
|
2,442 |
|
|
|
(4,700 |
)
|
|
Interest expense
|
|
|
— |
|
|
|
— |
|
|
|
(1,959 |
)
|
|
Interest income
|
|
|
— |
|
|
|
— |
|
|
|
410 |
|
|
Income (loss) before provision for income taxes
|
|
$
|
1,907 |
|
|
$
|
2,442 |
|
|
$
|
(6,249 |
)
|
|
Year Ended December 31, 2024
|
|
Dermatology Recurring Procedures
|
|
|
Dermatology Procedures Equipment
|
|
|
Total
|
|
| |
|
|
|
|
|
|
|
|
|
|
Revenues, net
|
|
$
|
21,171 |
|
|
$
|
12,391 |
|
|
$
|
33,562 |
|
|
Cost of revenues
|
|
|
7,799 |
|
|
|
6,541 |
|
|
|
14,340 |
|
|
Gross profit
|
|
|
13,372 |
|
|
|
5,850 |
|
|
|
19,222 |
|
|
Gross profit %
|
|
|
63.2 |
%
|
|
|
47.2 |
%
|
|
|
57.3 |
%
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocated expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Engineering and product development
|
|
|
658 |
|
|
|
225 |
|
|
|
883 |
|
|
Selling and marketing
|
|
|
11,140 |
|
|
|
1,290 |
|
|
|
12,430 |
|
|
Impairment of goodwill
|
|
|
4,268 |
|
|
|
— |
|
|
|
4,268 |
|
|
Unallocated expenses
|
|
|
— |
|
|
|
— |
|
|
|
10,896 |
|
|
Total allocated and unallocated expenses
|
|
|
16,066 |
|
|
|
1,515 |
|
|
|
28,477 |
|
|
(Loss) income from operations
|
|
|
(2,694 |
)
|
|
|
4,335 |
|
|
|
(9,255 |
)
|
|
Interest expense
|
|
|
— |
|
|
|
— |
|
|
|
(2,107 |
)
|
|
Interest income
|
|
|
— |
|
|
|
— |
|
|
|
242 |
|
|
Other income
|
|
|
— |
|
|
|
— |
|
|
|
864 |
|
|
(Loss) income before benefit from income taxes
|
|
$
|
(2,694 |
)
|
|
$
|
4,335 |
|
|
$
|
(10,256 |
)
|
|
| Depreciation and Amortization by Reportable Segment |
For the years ended December 31, 2025 and 2024, depreciation and amortization by reportable segment were as follows (in thousands):
| |
|
Year Ended December 31,
|
|
| |
|
2025
|
|
|
2024
|
|
| |
|
|
|
|
|
|
|
Dermatology recurring procedures
|
|
$
|
3,817 |
|
|
$
|
4,471 |
|
|
Dermatology procedures equipment
|
|
|
305 |
|
|
|
485 |
|
|
Unallocated expenses
|
|
|
1 |
|
|
|
12 |
|
|
Total
|
|
$
|
4,123 |
|
|
$
|
4,968 |
|
|
| Disaggregation of Revenue by Geographical Region |
The following tables present the Company’s revenue disaggregated by geographical region for the years ended December 31, 2025 and 2024 (in thousands). Domestic refers to revenue from customers based in the United States, and foreign revenue is derived from the Company’s distributors primarily in Asia.
|
Year Ended December 31, 2025
|
|
Dermatology Recurring Procedures
|
|
|
Dermatology Procedures Equipment
|
|
|
Total
|
|
| |
|
|
|
|
|
|
|
|
|
|
Domestic
|
|
$
|
19,572 |
|
|
$
|
1,012 |
|
|
$
|
20,584 |
|
|
China
|
|
|
— |
|
|
|
3,355 |
|
|
|
3,355 |
|
|
Middle East
|
|
|
— |
|
|
|
1,896 |
|
|
|
1,896 |
|
|
Other foreign
|
|
|
1,906 |
|
|
|
2,955 |
|
|
|
4,861 |
|
|
Total
|
|
$
|
21,478 |
|
|
$
|
9,218 |
|
|
$
|
30,696 |
|
|
Year Ended December 31, 2024
|
|
Dermatology Recurring Procedures
|
|
|
Dermatology Procedures Equipment
|
|
|
Total
|
|
| |
|
|
|
|
|
|
|
|
|
|
Domestic
|
|
$
|
19,531 |
|
|
$
|
1,357 |
|
|
$
|
20,888 |
|
|
China
|
|
|
— |
|
|
|
4,069 |
|
|
|
4,069 |
|
|
Middle East
|
|
|
— |
|
|
|
2,766 |
|
|
|
2,766 |
|
|
Other foreign
|
|
|
1,640 |
|
|
|
4,199 |
|
|
|
5,839 |
|
|
Total
|
|
$
|
21,171 |
|
|
$
|
12,391 |
|
|
$
|
33,562 |
|
|
| Total Assets by Reportable Segment |
As of December 31, 2025 and 2024, total assets by reportable segment were as follows (in thousands):
| |
|
December 31,
|
|
| |
|
2025
|
|
|
2024
|
|
| |
|
|
|
|
|
|
|
Dermatology recurring procedures
|
|
$
|
15,744 |
|
|
$
|
20,521 |
|
|
Dermatology procedures equipment
|
|
|
6,102 |
|
|
|
5,081 |
|
|
Other unallocated assets
|
|
|
8,675 |
|
|
|
9,326 |
|
|
Total
|
|
$
|
30,521 |
|
|
$
|
34,928 |
|
|